ArticleBMC oral health2026
Survey of Norwegian orthodontists on the use of temporary anchorage devices.
Article in BMC oral health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo assess Norwegian orthodontists’ perspectives concerning use of Temporary Anchorage Devices (TADs). MATERIALS AND
methodsA web-based survey (78 questions) was distributed to all 345 members of the Norwegian Association of Orthodontists. Descriptive statistics, cross-tabulations, Chi-square, Fisher’s Exact, or Kruskal-Wallis tests were applied.
resultsSeventy-one orthodontists responded (low response rate of 20.6%). Use of TADs in the buccal/lingual alveolar process, buccal shelf or retromolar pad (ABR) was reported by 41.5%; 29.2% were previous users, 9.2% intended future use, and 20.0% had never used. For palatal TADs, corresponding values were 29.2%, 15.4%, 23.1%, 32.3%; for miniplates: 0%, 10.8%, 21.5% and 67.7%. No associations were found between TAD use and orthodontists’ demographics, clinical experience, or practice type. Common indications included molar mesialization, distalization and posterior intrusion – the latter related to practitioner experience (P = 0.041). Frequent complications included screw loosening (91.3%) and soft-tissue overgrowth/irritation (80.4%). Barriers to use included procedural invasiveness and insufficient training, while discontinuation was attributed to complications, chair time, failures, invasiveness and patient discomfort. Over the preceding five years, 23.9% reported increased use, while 43.5% noted a decline. Among current users, satisfaction with ABR and palatal TADs was 69.2% and 70.6%, respectively. The respondents reported reduced treatment time (55.1%) and improved predictability (79%) when TADs were used.
conclusionsAmong responding Norwegian orthodontists, TAD use was reported by a moderate proportion, with a noted decline over the five years preceding the survey. Among users, satisfaction was generally high. All forms of relevant education were identified as key factors in their adoption.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.